Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOregon Health and Science University

About this trial

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Eligibility criteria

Qualifiers

Patient-defined regular use of methamphetamine in the last year

Any methamphetamine use in the past 30 days

Age 18 years or older

No client-reported diagnosis of heart failure

Disqualifiers

Self-reported engagement in medical care for heart failure in past 6 months.

Actively taking medications for heart failure.

Trial design

Treatments tested in this trial

  • Treatment as Usual
  • Telehealth-Cardiology

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Oregon Health and Science University

Lead sponsor

University of Washington

Collaborator

Bay Area First Step

Collaborator